Drug Patent List
Oppositions
Newsletter
Weekly Digest

Pharsight

Solifenacin Succinate Patent Expiration

Solifenacin Succinate was first introduced by Astellas Pharma Us Inc in its drug Vesicare on Nov 19, 2004. Another drug containing Solifenacin Succinate is Vesicare Ls. 25 different companies have introduced drugs containing Solifenacin Succinate.


Solifenacin Succinate Patents

Given below is the list of patents protecting Solifenacin Succinate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Vesicare US6017927 Quinuclidine derivatives and medicinal composition thereof Nov 19, 2018

(Expired)

 Astellas
Vesicare US6017927

(Pediatric)

 Quinuclidine derivatives and medicinal composition thereof May 19, 2019

(Expired)

 Astellas
Vesicare Ls US9918970 Pharmaceutical composition comprising solifenacin May 18, 2031 Astellas


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Solifenacin Succinate's patents.

Given below is the list recent legal activities going on the following patents of Solifenacin Succinate.

Event Date Patent/Publication
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 08 Sep, 2021 US9918970
Recordation of Patent Grant Mailed 20 Mar, 2018 US9918970
Patent Issue Date Used in PTA Calculation 20 Mar, 2018 US9918970
Mail Pre-Exam Notice 01 Mar, 2018 US9918970
Email Notification 01 Mar, 2018 US9918970
Electronic Review 01 Mar, 2018 US9918970
Issue Notification Mailed 28 Feb, 2018 US9918970
Dispatch to FDC 26 Jan, 2018 US9918970
Reverse Issue Fee 19 Jan, 2018 US9918970
Issue Fee Payment Verified 18 Jan, 2018 US9918970



Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Solifenacin Succinate Generics

Several generic applications have been filed for Solifenacin Succinate. The first generic version for Solifenacin Succinate was by Teva Pharmaceuticals Usa and was approved on Apr 2, 2014. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on Feb 20, 2024.

Given below is the list of companies who have filed for Solifenacin Succinate generic.


1. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG tablet Prescription ORAL AB Sep 26, 2019
10MG tablet Prescription ORAL AB Sep 26, 2019


2. LANNETT CO INC

Lannett Co Inc has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG tablet Discontinued ORAL N/A Jun 6, 2023
5MG tablet Discontinued ORAL N/A Jun 6, 2023


3. UNICHEM

Unichem Laboratories Ltd has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Unichem.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG tablet Prescription ORAL AB Aug 27, 2019
5MG tablet Prescription ORAL AB Aug 27, 2019


4. MSN

Msn Laboratories Private Ltd has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Msn.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG tablet Prescription ORAL AB May 20, 2019
5MG tablet Prescription ORAL AB May 20, 2019


5. SUNSHINE

Sunshine Lake Pharma Co Ltd has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Sunshine.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG tablet Discontinued ORAL N/A Apr 13, 2020
5MG tablet Discontinued ORAL N/A Apr 13, 2020


6. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG tablet Prescription ORAL AB Dec 27, 2022
5MG tablet Prescription ORAL AB Dec 27, 2022


7. QILU

Qilu Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Qilu.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG tablet Prescription ORAL AB May 20, 2019
10MG tablet Prescription ORAL AB May 20, 2019


8. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG tablet Prescription ORAL AB May 20, 2019
10MG tablet Prescription ORAL AB May 20, 2019


9. WATSON LABS INC

Watson Laboratories Inc has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG tablet Prescription ORAL AB May 20, 2019
10MG tablet Prescription ORAL AB May 20, 2019


10. CIPLA

Cipla Ltd has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Cipla.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG tablet Discontinued ORAL N/A May 20, 2019
10MG tablet Discontinued ORAL N/A May 20, 2019


11. TEVA PHARMS USA

Teva Pharmaceuticals Usa has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG tablet Prescription ORAL AB Apr 2, 2014
10MG tablet Prescription ORAL AB Apr 2, 2014


12. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG tablet Discontinued ORAL N/A Oct 19, 2020
5MG tablet Discontinued ORAL N/A Oct 19, 2020


13. AMNEAL PHARMS CO

Amneal Pharmaceuticals Co Gmbh has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Amneal Pharms Co.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG tablet Discontinued ORAL N/A May 20, 2019
10MG tablet Discontinued ORAL N/A May 20, 2019


14. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG tablet Discontinued ORAL N/A Jan 4, 2022
5MG tablet Discontinued ORAL N/A Jan 4, 2022


15. AUSTARPHARMA

Austarpharma Llc has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Austarpharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG tablet Prescription ORAL AB May 20, 2019
10MG tablet Prescription ORAL AB May 20, 2019


16. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG tablet Prescription ORAL AB May 20, 2019
10MG tablet Prescription ORAL AB May 20, 2019


17. AJANTA PHARMA LTD

Ajanta Pharma Ltd has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG tablet Discontinued ORAL N/A May 20, 2019
10MG tablet Discontinued ORAL N/A May 20, 2019


18. SCIEGEN PHARMS INC

Sciegen Pharmaceuticals Inc has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG tablet Prescription ORAL AB May 20, 2019
5MG tablet Prescription ORAL AB May 20, 2019


19. MACLEODS PHARMS LTD

Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG tablet Prescription ORAL AB Feb 20, 2024
5MG tablet Prescription ORAL AB Feb 20, 2024


20. GLENMARK SPECLT

Glenmark Specialty Sa has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Glenmark Speclt.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG tablet Prescription ORAL AB May 20, 2019
10MG tablet Prescription ORAL AB May 20, 2019


21. RISING

Rising Pharma Holdings Inc has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG tablet Prescription ORAL AB Dec 11, 2019
5MG tablet Prescription ORAL AB Dec 11, 2019


22. BRECKENRIDGE

Breckenridge Pharmaceutical Inc has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Breckenridge.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG tablet Discontinued ORAL N/A May 20, 2019
10MG tablet Discontinued ORAL N/A May 20, 2019


23. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG tablet Prescription ORAL AB May 20, 2019
5MG tablet Prescription ORAL AB May 20, 2019


24. ANNORA PHARMA

Annora Pharma Private Ltd has filed for 2 different strengths of generic version for Solifenacin Succinate. Given below are the details of the strengths of this generic introduced by Annora Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG tablet Prescription ORAL AB Jun 15, 2022
5MG tablet Prescription ORAL AB Jun 15, 2022